Supplementary Table 2 from Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan (GTX-CI) as First-line Treatment for Metastatic Pancreatic Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 2: Related Adverse Events
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4385455181